Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

148 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pretargeted radioimmunotherapy of colorectal cancer metastases: models and pharmacokinetics predict influence of the physical and radiochemical properties of the radionuclide.
Frampas E, Maurel C, Remaud-Le Saëc P, Mauxion T, Faivre-Chauvet A, Davodeau F, Goldenberg DM, Bardiès M, Barbet J. Frampas E, et al. Among authors: bardies m. Eur J Nucl Med Mol Imaging. 2011 Dec;38(12):2153-64. doi: 10.1007/s00259-011-1903-0. Epub 2011 Aug 20. Eur J Nucl Med Mol Imaging. 2011. PMID: 21858527
Bifunctional antibodies for radioimmunotherapy.
Chatal JF, Faivre-Chauvet A, Bardies M, Peltier P, Gautherot E, Barbet J. Chatal JF, et al. Among authors: bardies m. Hybridoma. 1995 Apr;14(2):125-8. doi: 10.1089/hyb.1995.14.125. Hybridoma. 1995. PMID: 7590767 Review.
Validation of 213Bi-alpha radioimmunotherapy for multiple myeloma.
Couturier O, Faivre-Chauvet A, Filippovich IV, Thédrez P, Saï-Maurel C, Bardiès M, Mishra AK, Gauvrit M, Blain G, Apostolidis C, Molinet R, Abbe JC, Bataille R, Wijdenes J, Chatal JF, Chérel M. Couturier O, et al. Among authors: bardies m. Clin Cancer Res. 1999 Oct;5(10 Suppl):3165s-3170s. Clin Cancer Res. 1999. PMID: 10541359
Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: preliminary results of a phase I/II clinical trial.
Kraeber-Bodéré F, Bardet S, Hoefnagel CA, Vieira MR, Vuillez JP, Murat A, Ferreira TC, Bardiès M, Ferrer L, Resche I, Gautherot E, Rouvier E, Barbet J, Chatal JF. Kraeber-Bodéré F, et al. Among authors: bardies m. Clin Cancer Res. 1999 Oct;5(10 Suppl):3190s-3198s. Clin Cancer Res. 1999. PMID: 10541363 Clinical Trial.
148 results